What is the initial management for a patient presenting to the emergency room (ER) with severe asthma, considering their past medical history and current medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe Asthma in the Emergency Room

Immediately administer high-flow oxygen (40-60% via face mask or reservoir mask at 15 L/min if SpO₂ <85%), nebulized salbutamol 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer, and systemic corticosteroids (prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg) within the first few minutes of arrival. 1, 2

Initial Assessment and Recognition

Upon arrival, rapidly assess for features of severe or life-threatening asthma:

Severe asthma features: 3, 1

  • Cannot complete sentences in one breath
  • Respiratory rate >25 breaths/min
  • Heart rate >110 beats/min
  • Peak expiratory flow (PEF) <50% of predicted or personal best

Life-threatening features: 3, 2

  • Silent chest, cyanosis, or feeble respiratory effort
  • Bradycardia or hypotension
  • Exhaustion, confusion, altered consciousness, or coma
  • SpO₂ <92%

First-Line Treatment Protocol (First Hour)

Step 1: Oxygen Therapy

  • Target SpO₂ >90% (>95% in pregnant patients or those with heart disease) 1, 2
  • Use high-flow oxygen 40-60% via face mask or reservoir mask at 15 L/min if initial SpO₂ <85% 3, 2
  • Continue oxygen monitoring until clear response to bronchodilator therapy occurs 1

Step 2: Nebulized Beta-Agonists

  • Administer salbutamol 5 mg OR terbutaline 10 mg via oxygen-driven nebulizer 3, 1
  • Repeat every 20 minutes for 3 doses in the first hour 1, 2
  • If no nebulizer available, give 2 puffs via large volume spacer and repeat (up to 20 puffs maximum) 3

Step 3: Systemic Corticosteroids (Administer Immediately)

  • Give prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg 3, 1
  • Critical point: Corticosteroids take 6-12 hours to show clinical effect, so early administration is essential 1, 4
  • Continue high-dose steroids: prednisolone 30-60 mg daily OR IV hydrocortisone 200 mg every 6 hours 1

Step 4: Add Ipratropium for Severe Cases

  • Add ipratropium bromide 0.5 mg to nebulized beta-agonist for severe exacerbations or inadequate response to initial therapy 1, 5, 6
  • Can be mixed in the nebulizer with albuterol if used within one hour 7

Reassessment at 15-30 Minutes

Measure PEF or FEV₁, assess symptoms, vital signs, and oxygen saturation 1:

If PEF >75% predicted: 3

  • Step up usual treatment
  • Consider discharge with close follow-up

If PEF 50-75% predicted: 3

  • Repeat nebulized beta-agonist
  • Give prednisolone 40 mg if not already administered
  • Wait 30 minutes and reassess

If PEF <50% predicted or severe features persist: 3

  • Arrange hospital admission
  • Continue intensive treatment

Additional Interventions for Life-Threatening or Refractory Cases

Intravenous Magnesium Sulfate

  • Give IV magnesium sulfate 2g over 20 minutes for severe exacerbations unresponsive to initial treatment 8, 5, 6

Parenteral Beta-Agonists or Aminophylline

  • Consider IV aminophylline 250 mg over 20 minutes OR subcutaneous terbutaline 250 µg for life-threatening exacerbations 3, 1
  • Caution: Use aminophylline with extreme caution if patient already taking theophyllines 3

Arterial Blood Gas Monitoring

  • Repeat arterial blood gases within 2 hours if initial PaO₂ <8 kPa or if PaCO₂ was normal/elevated 2

Critical Pitfalls to Avoid

Absolutely contraindicated: 1

  • Sedatives of any kind—never administer in acute asthma
  • Antibiotics unless bacterial infection (pneumonia/sinusitis) is confirmed

Avoid treatments lacking evidence: 8

  • Aggressive hydration or large volumes of liquids
  • Mucolytics
  • Chest physiotherapy
  • Over-the-counter antihistamines or cold remedies

Criteria for Hospital Admission

Admit if any of the following persist after initial treatment: 3, 1, 2

  • Any life-threatening features present
  • PEF <33% predicted after treatment
  • Features of severe attack persist after 1-2 hours of intensive treatment
  • PEF <50% predicted with inadequate response

Criteria for ICU Transfer

Transfer immediately if: 2

  • Deteriorating PEF despite treatment
  • Worsening or persisting hypoxia
  • Hypercapnia
  • Exhaustion, confusion, drowsiness, or altered mental status
  • Patient unconscious or confused—call ICU/anesthesia immediately and do not attempt intubation until most expert available doctor is present 3

Monitoring During Treatment

  • Measure and record PEF 15-30 minutes after starting treatment, then according to response 1
  • Monitor oxygen saturation continuously until clear response occurs 1, 8
  • Assess for signs of clinical deterioration requiring escalation of care 2

Special Considerations

High-risk patients requiring extra vigilance: 3

  • Previous ICU admissions or intubations
  • Recent hospitalizations or frequent ED visits
  • Poor perception of airflow obstruction severity
  • History of sudden severe (brittle) asthma

Stay with the patient until ambulance arrives if arranging transfer 3

References

Guideline

Emergency Asthma Treatment Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Emergency Management of Severe Asthma with Hypoxemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chapter 14: Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2012

Research

The acute management of asthma.

Clinical reviews in allergy & immunology, 2015

Guideline

Treatment of Dry Sore Throat in Asthmatic Patients Hospitalized for Exacerbation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.